1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 26
2.2 Major Growth Drivers 28
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porters Fiver Forces Analysis 42
3 Segmentation of Global Market by Drug Type 46
3.1 Market Overview by Drug Type 46
3.2 Small Molecule Drugs 48
3.3 Biologic Drugs 49
4 Segmentation of Global Market by Service 50
4.1 Market Overview by Service 50
4.2 Medicinal Chemical Services 52
4.3 Biological Services 53
4.4 Drug Metabolism and Pharmacokinetics (DMPK) Services 54
4.5 Other Pharmaceutical Services 55
5 Segmentation of Global Market by Process 56
5.1 Market Overview by Process 56
5.2 Target Selection 58
5.3 Target Validation 59
5.4 Hit-To-Lead Identification 60
5.5 Lead Optimization 61
5.6 Candidate Validation 62
6 Segmentation of Global Market by Technology 63
6.1 Market Overview by Technology 63
6.2 High Throughput Screening 65
6.3 Combinatorial Chemistry 66
6.4 Pharmacogenomics and Pharmacogenetics 67
6.5 Nanotechnology 68
6.6 Bioanalytical Instruments 69
6.7 Biochips 70
6.8 Bioinformatics 71
6.9 Other Technologies 72
7 Segmentation of Global Market by Therapeutic Area 73
7.1 Market Overview by Therapeutic Area 73
7.2 Oncology 75
7.3 Neurology 76
7.4 Infectious and Immune System Diseases 77
7.5 Digestive System Diseases 78
7.6 Cardiovascular Diseases 79
7.7 Diabetes 80
7.8 Respiratory Disease 81
7.9 Other Therapeutic Areas 82
8 Segmentation of Global Market by End User 83
8.1 Market Overview by End User 83
8.2 Pharmaceutical Companies 85
8.3 Contract Research Organizations (CROs) 86
8.4 Research Institutes 87
8.5 Other End Users 88
9 Segmentation of Global Market by Region 89
9.1 Geographic Market Overview 2019-2030 89
9.2 North America Market 2019-2030 by Country 94
9.2.1 Overview of North America Market 94
9.2.2 U.S. 98
9.2.3 Canada 104
9.2.4 Mexico 106
9.3 European Market 2019-2030 by Country 108
9.3.1 Overview of European Market 108
9.3.2 Germany 112
9.3.3 U.K. 114
9.3.4 France 116
9.3.5 Spain 118
9.3.6 Italy 120
9.3.7 Russia 122
9.3.8 Rest of European Market 124
9.4 Asia-Pacific Market 2019-2030 by Country 126
9.4.1 Overview of Asia-Pacific Market 126
9.4.2 Japan 130
9.4.3 China 133
9.4.4 Australia 135
9.4.5 India 137
9.4.6 South Korea 139
9.4.7 Rest of APAC Region 141
9.5 South America Market 2019-2030 by Country 143
9.5.1 Argentina 146
9.5.2 Brazil 148
9.5.3 Chile 150
9.5.4 Rest of South America Market 152
9.6 MEA Market 2019-2030 by Country 153
9.6.1 UAE 156
9.6.2 Saudi Arabia 158
9.6.3 South Africa 160
9.6.4 Other National Markets 162
10 Competitive Landscape 163
10.1 Overview of Key Vendors 163
10.2 New Product Launch, Partnership, Investment, and M&A 166
10.3 Company Profiles 167
Abbott Laboratories Inc. 167
Agilent Technologies Inc. 169
Astrazeneca plc 170
Bayer AG 171
Charles River Laboratories International Inc. 172
Eli Lilly and Company 173
F. Hoffmann-La Roche Ltd 174
GlaxoSmithKline PLC 175
Merck & Co. Inc. 176
Novartis AG 177
Pfizer Inc. 178
Shimadzu Corp 179
Thermo Fisher Scientific Inc. 180
RELATED REPORTS 181